Intermittent treatment of metastatic malignant melanoma with high-dose 5-(3,3-dimethyl-1-triazeno)imidazole-4-carboxamide (NSC-45388).
D000328:Adult; D000368:Aged; D001772:Blood Cell Count; D004304:Dosage Forms; D005260:Female; D005500:Follow-Up Studies; D006801:Humans; D007093:Imidazoles / Q000008:administration & dosage / Q000627:therapeutic use* / Q000633:toxicity; D008297:Male; D008545:Melanoma / Q000188:drug therapy*; D008875:Middle Aged; D013997:Time Factors
D004304:Dosage Forms; D007093:Imidazoles